Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 21, 2017 - Issue 10
Submit an article Journal homepage
281
Views
9
CrossRef citations to date
0
Altmetric
Review

Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer

Laura RosanòPreclinical Models and New Therapeutic Agents Unit, Translational Research Functional Departmental Area, Regina Elena National Cancer Institute, Rome, ItalyView further author information
,
Roberta CianfroccaPreclinical Models and New Therapeutic Agents Unit, Translational Research Functional Departmental Area, Regina Elena National Cancer Institute, Rome, ItalyView further author information
,
Rosanna SestitoPreclinical Models and New Therapeutic Agents Unit, Translational Research Functional Departmental Area, Regina Elena National Cancer Institute, Rome, ItalyView further author information
,
Piera TocciPreclinical Models and New Therapeutic Agents Unit, Translational Research Functional Departmental Area, Regina Elena National Cancer Institute, Rome, ItalyView further author information
,
Valeriana Di CastroPreclinical Models and New Therapeutic Agents Unit, Translational Research Functional Departmental Area, Regina Elena National Cancer Institute, Rome, ItalyView further author information
&
Anna BagnatoPreclinical Models and New Therapeutic Agents Unit, Translational Research Functional Departmental Area, Regina Elena National Cancer Institute, Rome, ItalyCorrespondence[email protected]
View further author information
Pages 925-932 | Received 01 Feb 2017, Accepted 27 Jul 2017, Published online: 05 Sep 2017

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Huey-En Tzeng, Chih-Hsin Tang, Chun-Hao Tsai, Chih-Hui Chiu, Min-Huan Wu & Yun Yen. (2021) ET-1 Promotes Epithelial–Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells via the microRNA-489-3p /TWIST Axis. OncoTargets and Therapy 14, pages 5005-5018.
Read now

Articles from other publishers (8)

Dmytro O. Minchenko, Olena O. Khita, Dariia O. Tsymbal, Yuliia M. Viletska, Myroslava Y. Sliusar, Yuliia V. Yefimova, Liudmyla O. Levadna, Dariia A. Krasnytska & Oleksandr H. Minchenko. (2021) ERN1 knockdown modifies the impact of glucose and glutamine deprivations on the expression of EDN1 and its receptors in glioma cells. Endocrine Regulations 55:2, pages 72-82.
Crossref
Terry W. Moody, Irene Ramos-Alvarez & Robert T. Jensen. (2021) Bombesin, endothelin, neurotensin and pituitary adenylate cyclase activating polypeptide cause tyrosine phosphorylation of receptor tyrosine kinases. Peptides 137, pages 170480.
Crossref
Georgia Koutsoumpli, Oana Draghiciu, Hans W Nijman, Cesar Oyarce & Toos Daemen. 2021. Cancer Immunology. Cancer Immunology 61 83 .
Hye-Mi Ahn, Dong-Gun Kim & Youn-Jae Kim. (2020) Blockade of endothelin receptor A enhances the therapeutic efficacy of gemcitabine in pancreatic cancer cells. Biochemical and Biophysical Research Communications 527:2, pages 568-573.
Crossref
Piera Tocci, Roberta Cianfrocca, Valeriana Di Castro, Laura Rosanò, Andrea Sacconi, Sara Donzelli, Silvia Bonfiglio, Gabriele Bucci, Enrico Vizza, Gabriella Ferrandina, Giovanni Scambia, Giovanni Tonon, Giovanni Blandino & Anna Bagnato. (2019) β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer. Nature Communications 10:1.
Crossref
Weisong Shen, Hongqing Xi, Chenyang Li, Shibo Bian, Haidong Cheng, Jianxin Cui, Ning Wang, Bo Wei, Xiaohui Huang & Lin Chen. (2019) Endothelin‐A receptor in gastric cancer and enhanced antitumor activity of trastuzumab in combination with the endothelin‐A receptor antagonist ZD4054. Annals of the New York Academy of Sciences 1448:1, pages 30-41.
Crossref
Xi Gu, Shuai Han, Meizi Cui, Jinqi Xue, Liping Ai, Lisha Sun, Xudong Zhu, Yulun Wang & Caigang Liu. (2019) Knockdown of endothelin receptor B inhibits the progression of triple‐negative breast cancer. Annals of the New York Academy of Sciences 1448:1, pages 5-18.
Crossref
Julio C. Tapia & Ignacio Niechi. (2019) Endothelin-converting enzyme-1 in cancer aggressiveness. Cancer Letters 452, pages 152-157.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.